Core Scientific, Inc.
CORZ
$19.63
-$0.16-0.78%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -19.17% | -13.45% | 79.62% | 28.07% | -44.90% |
| Total Depreciation and Amortization | -33.69% | -36.19% | -39.13% | -30.03% | -17.80% |
| Total Amortization of Deferred Charges | -0.08% | -46.73% | -30.01% | -13.13% | 40.17% |
| Total Other Non-Cash Items | 41.37% | 22.72% | -102.34% | -56.84% | 15.34% |
| Change in Net Operating Assets | 257.92% | 6,795.54% | 2,010.11% | 313.00% | 280.86% |
| Cash from Operations | 5,984.68% | 2,438.61% | 538.31% | 164.88% | -83.22% |
| Capital Expenditure | -455.65% | -600.32% | -663.01% | -514.67% | -436.65% |
| Sale of Property, Plant, and Equipment | 242.13% | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -4,620.91% | -97.07% | -6,484.85% | -8,160.87% | -2,007.38% |
| Cash from Investing | -536.70% | -579.16% | -673.50% | -668.00% | -653.36% |
| Total Debt Issued | 304.18% | -5.93% | -- | 36.31% | -- |
| Total Debt Repaid | -219.34% | 88.83% | 88.20% | 84.26% | -371.50% |
| Issuance of Common Stock | 32.98% | 23.51% | -89.07% | -92.35% | -91.36% |
| Repurchase of Common Stock | -25,316.17% | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1,005.65% | 64.19% | -103.88% | -112.86% | -126.13% |
| Cash from Financing | 325.14% | 19.90% | -107.70% | 174.19% | 13,454.72% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 306.83% | -23.47% | -168.50% | 5.15% | 2,280.14% |